Skip to main content
Clinical Trials/EUCTR2019-002032-84-CZ
EUCTR2019-002032-84-CZ
Active, not recruiting
Phase 1

Evaluating the Use of a Progesterone Receptor Modulator for Cervical Ripening at Full Term Pregnancy – a Randomized, Double-blind , placebo controlled Study (LUCYNA) - LUCYNA

Disphar International B.V0 sites150 target enrollmentJune 11, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Disphar International B.V
Enrollment
150
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 11, 2019
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
Disphar International B.V

Eligibility Criteria

Inclusion Criteria

  • Age 18 – 40 years
  • Pregnancy \= 40 Weeks \+ 5 days
  • Bishop Score \= 5
  • Intact membranes
  • BMI \= 30 before pregnancy
  • Primiparous women
  • Singleton pregnancy
  • Physiological pregnancy (no risk factors, no abnormalities in clinical and laboratory examinations during pregnancy)
  • Agreeing to participate in the study
  • Signed written informed consent for study participation

Exclusion Criteria

  • any contraindication to vaginal delivery
  • previous late abortion (\= 12 week of pregnancy)
  • uterine scar
  • cephalopelvic disproportion
  • placenta praevia
  • fetal malpresentation
  • chorioamnionitis
  • fetal congenital abnormalities
  • participation in a clinical trial with investigational drugs within the last 3 months before the enrolment or during the present trial period.
  • significant maternal cardiac, renal or hepatic disease or any condition,which in the opinion of the Investigator place the patient at an unacceptable risk level for participating in a study

Outcomes

Primary Outcomes

Not specified

Similar Trials